OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2024.14245 OL-27-3-14245 Retraction [Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor ZhuWenyan MaYongchi ZhuangXuqin JinXin 03 2024 22 01 2024 27 3 112 Copyright: © Zhu et al. 2024 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 15: 6345–6351, 2018; DOI: 10.3892/ol.2018.8128

Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Figs. 3B and 6C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Letters, or were under consideration for publication at around the same time (some of which have been retracted).

In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Letters has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.